Skip to content

Clinical trials

Phase 4 Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 4 Country / region: United States Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20053
20065
20072
20092
20103
20111
20123
20133
20141
20153
20162
20173
20184
20191
20201
20211
20222
20231
20241
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated8
Recruiting4
Unknown status4
Withdrawn2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.3
University of Cincinnati3
Kimford Jay Meador2
University of Maryland, Baltimore2
Wake Forest University Health Sciences2
Azurity Pharmaceuticals1
Boston Children's Hospital1
Boston VA Research Institute, Inc.1
Carilion Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy50
Seizures15
Anxiety Disorders5
Epilepsies, Partial5
Attention Deficit Disorder with Hyperactivity3
Nervous System Diseases3
Brain Neoplasms2
Cognitive Dysfunction2
Drug Resistant Epilepsy2
Learning Disabilities2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.